Error
xxx
Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  COVID-19: Confidentiality, COVID-19 and consequences for future research design in and beyond the pandemic
Webinar
COVID-19: Confidentiality, COVID-19 and consequences for future research design in and beyond the pandemic
Quality and ethics experts respond to your questions from sponsor and site points of view.
12th July 2021 - 17:00-18:00 CESTAdd to calendar
Description
Description

Our Free of Charge Monthly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.

    Confidentiality, COVID-19 and consequences for future research design in and beyond the pandemic

    Moderator: Seif Eddine Amara Madi, GSK

    Agenda
  • Opening:
    Hugh Davies, National Research Ethics Service, UK
  • Confidentiality - the ethical principles of fair data use
    Hugh Davies, National Research Ethics Service, UK
  • Panel and audience discussion: Confidentiality and its implications of research design
  • Confidentiality and the COVID 19 pandemic: what’s changed?
    Hugh Davies, National Research Ethics Service, UK

  • Panelists: A selection of our EFGCP Subject Matter Experts will be on hand to join in the discussion and respond to questions
  • Louise Mawer, Mirabilitas
  • Beat Widler, WS QMS
  • Mark Poulton, Poulton Quality Solutions
  • Belinda Pierce, BP Quality Solutions
  • Heather Sampson, University of Toronto

It is important to ask your Questions Upfront so that the team can answer adequately, please submit your questions using the following link: Click Here
Ask us
If you have any question, send us an email to info@efgcp.eu
Follow us
Linkedin
Twitter
EFGCP
European Forum for Good Clinical Practice
Rue de Washington 40
B-1050 Brussels - Belgium
Tel : +32 2 732 87 83
TVA : BE 0457 666 685